SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-05-000747
Filing Date
2005-04-29
Accepted
2005-04-28 19:39:54
Documents
15
Period of Report
2005-06-10
Effectiveness Date
2005-04-29

Document Format Files

Seq Description Document Type Size
1 d16703.htm DEF 14A 382840
2 GRAPHIC d16703_kolinski.jpg GRAPHIC 6649
3 GRAPHIC d16703_linechart.jpg GRAPHIC 54513
4 GRAPHIC d16703_regeneron.jpg GRAPHIC 16854
5 GRAPHIC d16703_vagelos.jpg GRAPHIC 6164
6 GRAPHIC g16703_imghtmx7x1.jpg GRAPHIC 9325
7 GRAPHIC g16703_imghtmx7x2.jpg GRAPHIC 8962
8 GRAPHIC g16703_imghtmx8x1.jpg GRAPHIC 9352
9 GRAPHIC g16703_imghtmx8x2.jpg GRAPHIC 9481
10 GRAPHIC g16703_imghtmx8x3.jpg GRAPHIC 9830
11 GRAPHIC g16703_imghtmx8x4.jpg GRAPHIC 9190
12 GRAPHIC g16703_imghtmx9x1.jpg GRAPHIC 9189
13 GRAPHIC g16703_imghtmx9x2.jpg GRAPHIC 9141
14 GRAPHIC g16703_imghtmx9x3.jpg GRAPHIC 8365
15 GRAPHIC g16703_imghtmx9x4.jpg GRAPHIC 9208
  Complete submission text file 0001206774-05-000747.txt   629175
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19034 | Film No.: 05782266
SIC: 2834 Pharmaceutical Preparations